John Rim Highlights Stable Q1 2026 Growth as Samsung Biologics Expands Manufacturing Capacity

"In the first quarter, Samsung Biologics delivered stable growth, supported by consistent execution across our manufacturing network and continued demand f...

April 23, 2026 | Thursday | Company results
Crown Bioscience Partners with Turbine to Advance Translational Oncology with Integrated In Silico and Organoid Platforms

 Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced a strategic partnership with Turbine, a ...

April 23, 2026 | Thursday | News
Specialised Therapeutics Secures Australia and Singapore Approval for ZEPZELCA–Tecentriq in ES-SCLC

  ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), is approved for use in Australia and Singapore as a first-...

April 22, 2026 | Wednesday | News
Entos Pharmaceuticals Inc Partners With L-CMD Research Foundation To Advance Gene Therapy For Rare Muscular Dystrophy

  Entos Pharmaceuticals Inc (Entos), a clinical-stage company that develops genetic medicines utilizing its non-viral, redosable Fusogenix PLV delive...

April 22, 2026 | Wednesday | News
CPC Biotech Introduces High Temperature PPSU Connectors For Advanced Bioprocessing

  CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processi...

April 22, 2026 | Wednesday | News
Eli Lilly and Company To Acquire Kelonia Therapeutics In Up To $7 Billion Deal To Advance In Vivo CAR T Innovation

  Kelonia's lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for relapsed/refractory mul...

April 22, 2026 | Wednesday | News
Charles River Strengthens Biosafety And Quality Control Capabilities With Completion Of PathoQuest Acquisition

  Charles River Laboratories International, Inc. has announced the successful completion of its acquisition of PathoQuest, a specialist in ne...

April 21, 2026 | Tuesday | News
Evaxion’s AI-Designed Cancer Vaccine EVX-01 Shows Record Immune Response Rates in Phase 2 Melanoma Trial

New phase 2 data from personalized cancer vaccine EVX-01 demonstrates a record-high rate of vaccine targets triggering a tumor-specific immune response...

April 21, 2026 | Tuesday | News
Making Nucleic Acid Therapeutics Manufacturing More Sustainable at Scale

The demand for nucleic acid therapeutics (NATs) is rapidly altering the therapeutic landscape across a wide range of diseases. Recent industry data highlig...

April 20, 2026 | Monday | Expert Opinion
Oncodesign Services Expands Radionuclide Access Through Extended Collaboration with GIP ARRONAX

Oncodesign Services has extended its collaboration with GIP ARRONAX to secure access to astatine-211 (At-211) as well as other radionuclides used in targ...

April 20, 2026 | Monday | News
Repligen Opens New Training & Innovation Center in the Netherlands to Strengthen Global Bioprocessing Support

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new ...

April 20, 2026 | Monday | News
Evaxion’s EVX-01 Shows Record 86% Immune Response Rate in Phase 2 Personalized Cancer Vaccine Study

New phase 2 data from personalized cancer vaccine EVX-01 demonstrates a record-high rate of vaccine targets triggering a tumor-specific immune response...

April 20, 2026 | Monday | News
MasterControl Announces Workforce Reduction As Part Of Strategic Restructuring Effort

  MasterControl, a leading provider of quality and manufacturing software solutions for life sciences and regulated industries, has a...

April 20, 2026 | Monday | News
PacBio and Covaris Unveil Integrated Workflow to Unlock HiFi Sequencing from FFPE Tumor Samples

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample...

April 17, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close